Literature DB >> 21295093

Cancer cell invasion: treatment and monitoring opportunities in nanomedicine.

Omid Veiseh1, Forrest M Kievit, Richard G Ellenbogen, Miqin Zhang.   

Abstract

Cell invasion is an intrinsic cellular pathway whereby cells respond to extracellular stimuli to migrate through and modulate the structure of their extracellular matrix (ECM) in order to develop, repair, and protect the body's tissues. In cancer cells this process can become aberrantly regulated and lead to cancer metastasis. This cellular pathway contributes to the vast majority of cancer related fatalities, and therefore has been identified as a critical therapeutic target. Researchers have identified numerous potential molecular therapeutic targets of cancer cell invasion, yet delivery of therapies remains a major hurdle. Nanomedicine is a rapidly emerging technology which may offer a potential solution for tackling cancer metastasis by improving the specificity and potency of therapeutics delivered to invasive cancer cells. In this review we examine the biology of cancer cell invasion, its role in cancer progression and metastasis, molecular targets of cell invasion, and therapeutic inhibitors of cell invasion. We then discuss how the field of nanomedicine can be applied to monitor and treat cancer cell invasion. We aim to provide a perspective on how the advances in cancer biology and the field of nanomedicine can be combined to offer new solutions for treating cancer metastasis.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21295093      PMCID: PMC3132387          DOI: 10.1016/j.addr.2011.01.010

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  214 in total

Review 1.  Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.

Authors:  Xiaowei Dong; Russell J Mumper
Journal:  Nanomedicine (Lond)       Date:  2010-06       Impact factor: 5.307

Review 2.  Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

Authors:  David J Begley
Journal:  Pharmacol Ther       Date:  2004-10       Impact factor: 12.310

3.  Shape effects of filaments versus spherical particles in flow and drug delivery.

Authors:  Yan Geng; Paul Dalhaimer; Shenshen Cai; Richard Tsai; Manorama Tewari; Tamara Minko; Dennis E Discher
Journal:  Nat Nanotechnol       Date:  2007-03-25       Impact factor: 39.213

Review 4.  Magnetic nanoparticles in MR imaging and drug delivery.

Authors:  Conroy Sun; Jerry S H Lee; Miqin Zhang
Journal:  Adv Drug Deliv Rev       Date:  2008-04-10       Impact factor: 15.470

5.  Rapid pharmacokinetic and biodistribution studies using cholorotoxin-conjugated iron oxide nanoparticles: a novel non-radioactive method.

Authors:  Michelle Jeung-Eun Lee; Omid Veiseh; Narayan Bhattarai; Conroy Sun; Stacey J Hansen; Sally Ditzler; Sue Knoblaugh; Donghoon Lee; Richard Ellenbogen; Miqin Zhang; James M Olson
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

6.  Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects.

Authors:  Weibo Cai; Dong-Woon Shin; Kai Chen; Olivier Gheysens; Qizhen Cao; Shan X Wang; Sanjiv S Gambhir; Xiaoyuan Chen
Journal:  Nano Lett       Date:  2006-04       Impact factor: 11.189

7.  Coupling growth-factor engineering with nanotechnology for therapeutic angiogenesis.

Authors:  Rituparna Sinha Roy; Shivani Soni; Rania Harfouche; Pooja R Vasudevan; Oliver Holmes; Hugo de Jonge; Arthur Rowe; Abhimanyu Paraskar; Dirk M Hentschel; Dimitri Chirgadze; Tom L Blundell; Ermanno Gherardi; Raghunath A Mashelkar; Shiladitya Sengupta
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-16       Impact factor: 11.205

Review 8.  Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis.

Authors:  M E Muroski; M D Roycik; R G Newcomer; P E Van den Steen; G Opdenakker; H R Monroe; Z J Sahab; Q-X Sang
Journal:  Curr Pharm Biotechnol       Date:  2008-02       Impact factor: 2.837

Review 9.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

Review 10.  Targeting multidrug resistance in cancer.

Authors:  Gergely Szakács; Jill K Paterson; Joseph A Ludwig; Catherine Booth-Genthe; Michael M Gottesman
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

View more
  27 in total

Review 1.  Strategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and market.

Authors:  Michele F Oliveira; Pedro P G Guimarães; Alinne D M Gomes; Diego Suárez; Rubén D Sinisterra
Journal:  J Chem Biol       Date:  2012-11-30

2.  Hexanoyl-Chitosan-PEG Copolymer Coated Iron Oxide Nanoparticles for Hydrophobic Drug Delivery.

Authors:  Meng-Hsuan Hsiao; Qingxin Mu; Zachary R Stephen; Chen Fang; Miqin Zhang
Journal:  ACS Macro Lett       Date:  2015-03-23       Impact factor: 6.903

Review 3.  Current Advances in Black Phosphorus-Based Drug Delivery Systems for Cancer Therapy.

Authors:  Wenxin Liu; Alideertu Dong; Bing Wang; Han Zhang
Journal:  Adv Sci (Weinh)       Date:  2021-01-15       Impact factor: 16.806

4.  In vivo safety evaluation of polyarginine coated magnetic nanovectors.

Authors:  Omid Veiseh; Forrest M Kievit; Vicki Liu; Chen Fang; Zachary R Stephen; Richard G Ellenbogen; Miqin Zhang
Journal:  Mol Pharm       Date:  2013-10-21       Impact factor: 4.939

5.  Silibinin and indocyanine green-loaded nanoparticles inhibit the growth and metastasis of mammalian breast cancer cells in vitro.

Authors:  Hui-Ping Sun; Jing-Han Su; Qing-Shuo Meng; Qi Yin; Zhi-Wen Zhang; Hai-Jun Yu; Peng-Cheng Zhang; Si-Ling Wang; Ya-Ping Li
Journal:  Acta Pharmacol Sin       Date:  2016-05-02       Impact factor: 6.150

6.  Preparation of pyrenyl-based multifunctional nanocomposites for biomedical applications.

Authors:  Eun-Kyung Lim; Bong Hyun Chung
Journal:  Nat Protoc       Date:  2016-01-07       Impact factor: 13.491

7.  Aligned chitosan-polycaprolactone polyblend nanofibers promote the migration of glioblastoma cells.

Authors:  Forrest M Kievit; Ashleigh Cooper; Soumen Jana; Matthew C Leung; Kui Wang; Dennis Edmondson; David Wood; Jerry S H Lee; Richard G Ellenbogen; Miqin Zhang
Journal:  Adv Healthc Mater       Date:  2013-06-17       Impact factor: 9.933

Review 8.  Biological rationale for the design of polymeric anti-cancer nanomedicines.

Authors:  Yan Zhou; Jindřich Kopeček
Journal:  J Drug Target       Date:  2012-09-26       Impact factor: 5.121

Review 9.  Targeting tumor metastases: Drug delivery mechanisms and technologies.

Authors:  Vidya Ganapathy; Prabhas V Moghe; Charles M Roth
Journal:  J Control Release       Date:  2015-09-25       Impact factor: 9.776

Review 10.  Development of individualized anti-metastasis strategies by engineering nanomedicines.

Authors:  Qianjun He; Shengrong Guo; Zhiyong Qian; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2015-06-09       Impact factor: 54.564

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.